JP2005525325A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525325A5
JP2005525325A5 JP2003564060A JP2003564060A JP2005525325A5 JP 2005525325 A5 JP2005525325 A5 JP 2005525325A5 JP 2003564060 A JP2003564060 A JP 2003564060A JP 2003564060 A JP2003564060 A JP 2003564060A JP 2005525325 A5 JP2005525325 A5 JP 2005525325A5
Authority
JP
Japan
Prior art keywords
mmol
stirred
isonitrile
vacuo
aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003564060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525325A (ja
Filing date
Publication date
Priority claimed from DE10204072A external-priority patent/DE10204072A1/de
Priority claimed from DE10300049A external-priority patent/DE10300049A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/001011 external-priority patent/WO2003064440A1/de
Publication of JP2005525325A publication Critical patent/JP2005525325A/ja
Publication of JP2005525325A5 publication Critical patent/JP2005525325A5/ja
Pending legal-status Critical Current

Links

JP2003564060A 2002-01-31 2003-01-31 Xa因子活性を阻害する化合物 Pending JP2005525325A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10204072A DE10204072A1 (de) 2002-01-31 2002-01-31 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren
DE10300049A DE10300049A1 (de) 2003-01-03 2003-01-03 Neue Verbindungen, die Faktor VIIa inhibieren
PCT/EP2003/001011 WO2003064440A1 (de) 2002-01-31 2003-01-31 Verbindungen, die faktor xa-aktivät inhibieren

Publications (2)

Publication Number Publication Date
JP2005525325A JP2005525325A (ja) 2005-08-25
JP2005525325A5 true JP2005525325A5 (https=) 2006-03-09

Family

ID=27664555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564060A Pending JP2005525325A (ja) 2002-01-31 2003-01-31 Xa因子活性を阻害する化合物

Country Status (13)

Country Link
US (1) US20050049283A1 (https=)
EP (1) EP1470143B1 (https=)
JP (1) JP2005525325A (https=)
KR (1) KR20040096541A (https=)
CN (1) CN1322001C (https=)
AT (1) ATE377017T1 (https=)
BR (1) BR0307266A (https=)
CA (1) CA2473169A1 (https=)
DE (1) DE50308492D1 (https=)
MX (1) MXPA04007461A (https=)
NZ (1) NZ534238A (https=)
PL (1) PL369772A1 (https=)
WO (1) WO2003064440A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060135781A (ko) * 2004-02-25 2006-12-29 라 졸라 파마슈티칼 컴파니 질병의 치료를 위한 아민 및 아미드
ES2365815T3 (es) * 2005-12-14 2011-10-11 Bristol-Myers Squibb Company Análogos de arilpropionamida, arilacrilamida, arilpropinamida o arilmetilurea como inhibidores del factor xia.
EP1981854B1 (en) 2005-12-14 2011-06-01 Bristol-Myers Squibb Company Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
WO2017156071A1 (en) 2016-03-09 2017-09-14 Blade Therapeutics, Inc. Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
EP3481835A4 (en) 2016-07-05 2020-02-26 Blade Therapeutics, Inc. CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
BR112019006110A2 (pt) 2016-09-28 2019-09-10 Blade Therapeutics Inc moduladores de calpaína e usos terapêuticos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614893B1 (fr) * 1987-05-04 1989-12-22 Fournier Innovation Synergie Nouveaux b-d-phenyl-thioxylosides, leur procede de preparation et leur application en therapeutique
EP0560568A3 (en) * 1992-03-13 1994-06-29 Takeda Chemical Industries Ltd Hydroquinone derivatives and intermediates for production thereof
EP0921116B1 (de) * 1997-12-04 2003-06-18 F. Hoffmann-La Roche Ag N-(4-carbamimido-phenyl)-glycinamidderivate
US6358960B1 (en) * 1998-02-17 2002-03-19 Ono Pharmaceutical Co., Ltd. Amidino derivatives and drugs containing the same as the active ingredient
US6486129B1 (en) * 1998-06-17 2002-11-26 Akzo Nobel N.V. Antithrombotic compounds
DE10041402A1 (de) * 2000-08-23 2002-03-14 Morphochem Ag Neue Verbindungen, die Faktor Xa-Aktivität inhibieren
PT1336605E (pt) * 2000-11-22 2006-06-30 Astellas Pharma Inc Derivados de fenol substituidos ou seus sais como inibidores do factor x de coagulacao

Similar Documents

Publication Publication Date Title
JP2007518723A5 (https=)
JP2007523139A5 (https=)
JP2005053931A5 (https=)
JP2002542342A5 (https=)
JP2004538039A5 (https=)
JP2012510524A5 (https=)
JP2005179362A5 (https=)
JP2005508905A5 (https=)
JP2006526031A5 (https=)
TW200716575A (en) 1,3,5-triazine derivative, method for producing the same, and organic electroluminescent device containing the same as component
NO20064669L (no) Dipeptidylpeptidaseinhibitorer
JP2007500753A5 (https=)
JP2010510976A5 (https=)
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
JP2005525325A5 (https=)
JP2013515755A5 (https=)
JP2003234133A5 (https=)
JP2006506356A5 (https=)
EP1468997A3 (en) Polymorphous forms of rosiglitazone maleate
JP2004527549A5 (https=)
JP2005511682A5 (https=)
JP2005519117A5 (https=)
EP1568697A4 (en) 1,3-BENZOTHIAZINONE DERIVATIVES, THEIR MANUFACTURING METHOD AND USE
JP2003238140A5 (https=)
JP2001261653A5 (https=)